Literature DB >> 33406607

The p53 Pathway and Metabolism: The Tree That Hides the Forest.

Airelle Lahalle1,2,3,4,5, Matthieu Lacroix1,2,3,4,5, Carlo De Blasio1,2,3,4,5, Madi Y Cissé6, Laetitia K Linares1,2,3,4, Laurent Le Cam1,2,3,4,5.   

Abstract

The p53 pathway is functionally inactivated in most, if not all, human cancers. The p53 protein is a central effector of numerous stress-related molecular cascades. p53 controls a safeguard mechanism that prevents accumulation of abnormal cells and their transformation by regulating DNA repair, cell cycle progression, cell death, or senescence. The multiple cellular processes regulated by p53 were more recently extended to the control of metabolism and many studies support the notion that perturbations of p53-associated metabolic activities are linked to cancer development, as well as to other pathophysiological conditions including aging, type II diabetes, and liver disease. Although much less documented than p53 metabolic activities, converging lines of evidence indicate that other key components of this tumor suppressor pathway are also involved in cellular metabolism through p53-dependent as well as p53-independent mechanisms. Thus, at least from a metabolic standpoint, the p53 pathway must be considered as a non-linear pathway, but the complex metabolic network controlled by these p53 regulators and the mechanisms by which their activities are coordinated with p53 metabolic functions remain poorly understood. In this review, we highlight some of the metabolic pathways controlled by several central components of the p53 pathway and their role in tissue homeostasis, metabolic diseases, and cancer.

Entities:  

Keywords:  aging; cancer; metabolic disease; metabolism; network; p53 pathway

Year:  2021        PMID: 33406607     DOI: 10.3390/cancers13010133

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  8 in total

1.  p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth.

Authors:  Huishan Sun; Li Li; Wei Li; Fan Yang; Zhenxi Zhang; Zizhao Liu; Wenjing Du
Journal:  EMBO Rep       Date:  2021-08-30       Impact factor: 9.071

Review 2.  p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics).

Authors:  Daniela Milani; Lorenzo Caruso; Enrico Zauli; Adi Mohammed Al Owaifeer; Paola Secchiero; Giorgio Zauli; Donato Gemmati; Veronica Tisato
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

Review 3.  Metabolic Disorders in Multiple Myeloma.

Authors:  Maria Gavriatopoulou; Stavroula A Paschou; Ioannis Ntanasis-Stathopoulos; Meletios A Dimopoulos
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

4.  Mutant p53-microRNA-200c-ZEB2-Axis-Induced CPT1C Elevation Contributes to Metabolic Reprogramming and Tumor Progression in Basal-Like Breast Cancers.

Authors:  Chen-Yun Wang; Cing-Hong Wang; Ru-Tsun Mai; Ting-Wen Chen; Chia-Wei Li; Chi-Hong Chao
Journal:  Front Oncol       Date:  2022-07-21       Impact factor: 5.738

5.  Interdiction in the Early Folding of the p53 DNA-Binding Domain Leads to Its Amyloid-Like Misfolding.

Authors:  Fernando Bergasa-Caceres; Herschel A Rabitz
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

6.  Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions.

Authors:  Katherine N Lynch; Joyce F Liu; Nikolas Kesten; Kin-Hoe Chow; Aniket Shetty; Ruiyang He; Mosammat Faria Afreen; Liping Yuan; Ursula A Matulonis; Whitfield B Growdon; Michael G Muto; Neil S Horowitz; Colleen M Feltmate; Michael J Worley; Ross S Berkowitz; Christopher P Crum; Bo R Rueda; Sarah J Hill
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

7.  DNA Methylation Levels of the TBX5 Gene Promoter Are Associated with Congenital Septal Defects in Mexican Paediatric Patients.

Authors:  Esbeidy García-Flores; José Manuel Rodríguez-Pérez; Verónica Marusa Borgonio-Cuadra; Gilberto Vargas-Alarcón; Juan Calderón-Colmenero; Juan Pablo Sandoval; José Antonio García-Montes; Víctor Manuel Espinoza-Gutiérrez; Juan Gerardo Reyes-García; Benny Giovanni Cazarín-Santos; Antonio Miranda-Duarte; Armando Gamboa-Domínguez; Nonanzit Pérez-Hernández
Journal:  Biology (Basel)       Date:  2022-01-08

Review 8.  Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma.

Authors:  Konstantinos Gousias; Theocharis Theocharous; Matthias Simon
Journal:  Biomedicines       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.